# Cyclophosphamide and Busulfan as Conditioning Regimen Before Allogeneic HSCT

> **NCT01779882** · NA · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 72 (actual)

## Conditions studied

- Myeloid Leukemia
- Precursor Myeloid Neoplasms
- Lymphoid Neoplasms

## Interventions

- **DRUG:** Busulfan-Cyclophosphamide as Conditioning Regimen before Allogeneic Hematopoietic Stem Cell Transplantation
- **DRUG:** Cyclophosphamide-Busulfan as Conditioning Regimen before Allogeneic Hematopoietic Stem Cell Transplantation

## Key facts

- **NCT ID:** NCT01779882
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2018-01-06
- **Final completion:** 2018-01-06
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2018-03-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01779882

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01779882, "Cyclophosphamide and Busulfan as Conditioning Regimen Before Allogeneic HSCT". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01779882. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*